Read this manager's filing book
Disclosed positions
Bruce & Co., Inc.: source evidence dated 2026-08-15T03:59:59.999Z.
- Issuer
- Abbvie
- Ticker
- ABBV
- Class
- Common
- Reported value
- $30,448,440
- Reported amount
- 121,000
- Unit
- SH
- Option
- None
The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.
What was reported for this quarter?
13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.
SEC 13F-HR: 0001104659-26-096709Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filings
Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filingsKeep reporting dates and units beside the answer, and inspect its original citations.
Disclosed positions
See the complete disclosed positions
| Abbvie | ABBV | Common | $30,448,440 | 121,000 | SH | None |
| Allstate | ALL | Common | $29,147,650 | 122,500 | SH | None |
| AerCap Holdings | AER | Common | $26,969,300 | 185,000 | SH | None |
| Nextera Energy | Unresolved | Common | $25,830,711 | 294,300 | SH | None |
| Merck | Unresolved | Common | $24,517,800 | 190,800 | SH | None |
| Uhaul B | UHAL.B | Common | $24,060,900 | 417,000 | SH | None |
| Duke Energy | DUK | Common | $18,330,809 | 144,816 | SH | None |
| Vicor | VICR | Common | $18,229,440 | 48,000 | SH | None |
| XCEL Energy | XEL | Common | $14,654,750 | 182,500 | SH | None |
| CMS Energy | CMS | Common | $11,704,500 | 153,000 | SH | None |
| AT & T | T | Common | $10,722,600 | 518,000 | SH | None |
| Apple | AAPL | Common | $10,677,384 | 36,900 | SH | None |
| Beta Bionics | BBNX | Common | $10,431,519 | 665,700 | SH | None |
| Insteel | IIIN | Common | $10,371,375 | 343,423 | SH | None |
| Abbott | ABT | Common | $10,190,102 | 112,300 | SH | None |
| Newmont | NEM | Common | $9,340,000 | 100,000 | SH | None |
| Avista | AVA | Common | $8,182,000 | 200,000 | SH | None |
| Archer Daniels | ADM | Common | $7,640,000 | 100,000 | SH | None |
| Bunge | BG | Common | $7,471,100 | 70,000 | SH | None |
| Supernus | SUPN | Common | $6,976,500 | 150,000 | SH | None |
| Pfizer | PFE | Common | $6,458,256 | 268,200 | SH | None |
| Darling Ingredients | DAR | Common | $5,735,100 | 105,000 | SH | None |
| Kodiak Sciences | KOD | Common | $5,649,200 | 145,000 | SH | None |
| Chemours | CC | Common | $5,130,000 | 250,000 | SH | None |
| Uhaul | UHAL | Common | $4,750,944 | 72,600 | SH | None |
| Lyondellbasell | LYB | Common | $3,159,000 | 60,000 | SH | None |
| Personalis | PSNL | Common | $3,122,200 | 233,000 | SH | None |
| Fate Theraputics | FATE | Common | $2,670,808 | 989,188 | SH | None |
| Eli Lilly | LLY | Common | $2,398,860 | 2,000 | SH | None |
| RLI | RLI | Common | $2,362,800 | 40,000 | SH | None |
| Apogee | APOG | Common | $2,287,000 | 50,000 | SH | None |
| FocalTherics | FOCL | Common | $2,272,217 | 438,652 | SH | None |
| XM Sirius | SIRI | Common | $1,647,859 | 55,784 | SH | None |
| Venture Global | VG | Common | $1,113,000 | 100,000 | SH | None |
| Ashland | Unresolved | Common | $988,350 | 15,000 | SH | None |
| Viatris | VTRS | Common | $916,212 | 57,696 | SH | None |
| Mannkind | MNKD | Common | $831,011 | 195,073 | SH | None |
| Bausch Health | Unresolved | Common | $611,320 | 124,000 | SH | None |
| 908 Devices | MASS | Common | $594,088 | 68,286 | SH | None |
| WEC Energy | WEC | Common | $460,658 | 3,945 | SH | None |
| Caribou Biosciences | CRBU | Common | $440,000 | 250,000 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 4 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.